← Leaderboards
Scott L Dax
Cersci Therapeutics, Inc.
$1,953,420
Attributed
$1,953,420
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2017–18$2M$1.5M$1M$500K$0
'17
'18
Funding mix
By agency
NIH$1,953,420 · 2
By mechanism
R44$1,728,420 · 1
R43$225,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Pain”
- Abraham Aizer Brody · New York University School Of Medicine$25,530,786
- Jeffrey Reich · Sparian Biosciences, Inc.$21,671,295
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Barbara Burtness · Yale University$11,235,253
- William Russell Renthal · Brigham And Women'S Hospital$11,023,625
Research focus
PainRattusHealthcare SystemsNovel TherapeuticsPharmaceutical PreparationsPropertyDiabetes MellitusFree RadicalsLeadMouse ModelPeripheral Nervous SystemPeroxonitriteAdverse EffectsPharmacologyAffectCostBaseDoseHeart DiseasesIn VivoLigandsMalignant NeoplasmsPainful NeuropathySeries
Grant awards (3)
Orally-Bioavailable Peroxynitrite Decomposition Catalyst Targeting Post-Surgical Pain$1,070,335
R44 · FY2018 · DA · contact PI
Orally-Bioavailable Peroxynitrite Decomposition Catalyst Targeting Post-Surgical Pain$658,085
R44 · FY2017 · DA · contact PI
Novel AMPK Activators for the Treatment of Neuropathic Pain$225,000
R43 · FY2017 · GM · contact PI